Media Coverage

The TSA has sped up technology deployments since the beginning of the Covid-19 pandemic as it moves to reduce literal touch points at airport screening stations. The effort has been undertaken to benefit the traveling public but also TSA staffers themselves. As of Dec. 15, 11 TSA agents have died of Covid-19. The technology deployments have centered around 3-D screening systems and automated ID authentication. The former diminishes the likelihood that passenger carry-on bags will have to be manually checked, the agency said, which in turn reduces interactions between agents and flyers.

The authorization granted to Moderna's vaccine highlights the role of Operation Warp Speed ​​set up by Washington to accelerate the quest for drugs and vaccines against Covid-19. With an "American-style" method: innovation, a lot of money, soldiers and a dose of marketing.

In this post, we focus on the logistical challenges associated with distributing different types of COVID-19 vaccines to millions of people, from urban centers to sparsely populated rural counties. To address those questions, we spoke with Julie Swann, a systems engineer with expertise in vaccine distribution whose work focuses on making health care and supply chains more efficient, effective and equitable. Swann is the department head and A. Doug Allison Distinguished Professor of the Fitts Department of Industrial and Systems Engineering at NC State.

When the first doses of a COVID-19 from Pfizer and BioNTech were administered across the United States on Monday, it marked the beginning of a mass distribution effor that hinges on an unlikely product: dry ice.

Several thousand doses of Pfizer's COVID-19 vaccine were quarantined in California and Alabama after the US authorities encountered a transit anomaly that caused the storage temperature to get too cold. According to Gen. Gustave Perna, the one overseeing the logistics for Operation Warp Speed, the doses never left the truck, but they have to ensure that this anomaly is safe.